Methylphenidate and Modafinil: egalitarian justice and policies of access to pharmacological cognitive enhancement.

dc.contributorLoewe, Daniel
dc.date.accessioned2022-01-28T17:11:22Z
dc.date.accessioned2022-11-08T20:39:19Z
dc.date.available2022-01-28T17:11:22Z
dc.date.available2022-11-08T20:39:19Z
dc.date.created2022-01-28T17:11:22Z
dc.identifierhttps://repositorio.uai.cl//handle/20.500.12858/3526
dc.identifier10.4067/S1726-569X2017000100179
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5149283
dc.description.abstractThe article addresses criteria for access to pharmacological cognitive enhancement technologies, especially modafinil and methylphenidate, to healthy adults. From the perspective of equalitarian justice and taking as point of reference Rawls' theory of justice it argues in favor of a policy of open market access, but facilitated for the worst-off.
dc.titleMethylphenidate and Modafinil: egalitarian justice and policies of access to pharmacological cognitive enhancement.
dc.typeArtículo WoS


Este ítem pertenece a la siguiente institución